Rajwanth Veluswamy, MD

Rajwanth R. Veluswamy, MD, MSCR, is an Assistant Professor of Medicine, Hematology and Medical Oncology, and a board certified medical oncologist who specializes in the treatment of lung cancer and other thoracic malignancies. He completed both a clinical fellowship in Hematology and Medical Oncology and a General Medicine research fellowship at the Icahn School of Medicine at Mount Sinai. Prior to this, he completed residency in Internal Medicine at Methodist Dallas Medical Center, and a research internship at MD Anderson Cancer Center in Houston. He earned his M.D. from the University of Szeged and a Masters of Science in Clinical Research at Mount Sinai.

Dr. Veluswamy’s research focuses on understanding the factors responsible for clinical outcomes in lung cancer patients, from patterns of care to differences in therapeutic drug efficacy. He has published extensively and presented his research at international meetings where he has received numerous merit awards. He received a prestigious ASCO Young Investigator Award in recognition and support of his research during fellowship. As a faculty member at Mount Sinai, he uses novel research methods to investigate complex mechanisms involved in cancer and its treatment, especially in molecular therapy and immunotherapy.

Dr. Veluswamy’s clinical interest is to provide personalized treatment that best fits each patient. He collaborates with a multidisciplinary team of experts and scientists that are highly active in the treatment and research of thoracic malignancies. He is dedicated to providing compassionate care to improve the lives of his patients and their families.